Search results
US FDA approves Amgen drug for small cell lung cancer
Reuters via Yahoo News· 30 minutes agoThe most common side effect was cytokine release syndrome, a potentially dangerous condition that...
Canaccord cuts Aptose Biosciences shares target, expects lead drug approval delay By Investing.com
Investing.com· 9 hours agoOn Thursday, Canaccord Genuity (TSX:CF) adjusted its price target on Aptose Biosciences...
Roche Shares Climb After Weight-Loss Drug Shows Efficacy in Early-Stage Trial
The Wall Street Journal· 8 hours agoRoche Holding said its weight-loss drug candidate achieved positive results in an early-stage trial,...
Wall Street Favorites: 3 Cannabis Stocks with Strong Buy Ratings for May 2024
InvestorPlace· 9 hours agoCannabis stocks to buy could see higher highs. For one, more Americans (about 88%) want to see...
Report: Prosecution of DEA drug cases down
WJTV Jackson· 53 minutes agoAlthough fentanyl drug use is rising across the United States, a new report found a decrease in drug case prosecutions referred by the Drug Enforcement...
2 Top Growth Stocks Down 24% and 50% to Buy With $100
Motley Fool via Yahoo Finance· 6 hours agoThis is Pfizer's obesity drug candidate that flopped in phase 2 testing as a twice-daily drug...
AstraZeneca selects new heart failure target with BenevolentAI
Pharmaceutical Technology via Yahoo Finance· 10 hours agoThis is the first target selected from the extended partnership between the companies. The target...
Roche says weight loss drug shows promising results in early trial
CNBC· 6 hours agoRoche on Thursday said its experimental weight loss drug showed promising results in an early-stage...
Citi raises Prime Medicine shares target on FDA Milestone By Investing.com
Investing.com· 10 hours agoOn Thursday, Citi upgraded Prime Medicine (NASDAQ:PRME) from Neutral to Buy, maintaining a shares ...
Eisai sets new revenue target for Alzheimer’s drug Leqembi
BioPharma Dive via Yahoo Finance· 1 day agoThe annual forecast, which comes as Eisai and Biogen have begun submitting a more convenient form of...
